In this issue:
Empagliflozin in hospitalised acute HF
Atrial shunt device for HFPEF
Ultrasound JVP height for predicting central venous congestion
MI and HF hospitalisations during COVID-19 pandemic
Glycaemic variability and hyperglycaemia in diabetics hospitalised for acute HF
Decongestion, kidney injury and prognosis in acute HF
Impact of penalties for hospitals on HF-associated readmissions
MRAs and empagliflozin in HFPEF
Frailty, guideline-directed medical therapy and outcomes in HFREF
PRD identifies ICD responders in nonischaemic cardiomyopathy
Please login below to download this issue (PDF)